Showing 24 out of 97 results
Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and …
Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 史密夫斐尔律师事务所就赛诺菲对信达生物3亿欧元股权投资提供法律服务
Leading international law firm Herbert Smith Freehills has advised innovative global healthcare company Sanofi on its €300 million strategic equity …
First things first: Full Federal Court clarifies the law on patent term extensions
Last week, a Full Court of the Federal Court of Australia handed down two unanimous decisions on appeal, clearing up some key uncertainties in the …
Herbert Smith Freehills advises sponsors and underwriters on Lepu Biopharma's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为乐普生物香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised CICC and Morgan Stanley as joint sponsors and the underwriters of biopharmaceutical …
Cyber-ransoms are on the rise: What do you need to know?
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the risks are increasing.KEY TAKEAWAYS A key question facing companies …
Herbert Smith Freehills advises sponsors on Brii Biosciences’ HK$2.483 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为腾盛博药24.83亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and UBS as joint sponsors of biopharmaceutical company Brii Biosciences …
FEDERAL COURT OVERTURNS ‘ABSURD’ PATENT OFFICE RULING ON PATENT TERM EXTENSIONS FOR PHARMACEUTICAL SUBSTANCES
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension (PTE) applications, upholding a challenge …
Pharmaceutical patent term extensions: federal court hears challenge to “absurd” Australian patent office ruling
Two major pharmaceutical companies have challenged Australia’s Commissioner of Patents in the Federal Court about the time limits within which an …
Judicial review and the life sciences and health sectors
The life sciences and healthcare sector is subject to complex regulation, and decisions of Government bodies can have a significant impact on the …
Patent and Pharma update, February 2021
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector. In this edition we cover an important …
THE IMPACT OF THE NEW ITALIAN FOREIGN INVESTMENTS RULES ON THE PHARMA SECTOR
Differently from certain sectors (such as energy, telecommunications and transportation) that have always been included in the scope of application of …
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
Showing 24 out of 97 results
View more